News & Updates

Donanemab administered for a limited duration continues to slow clinical progression in patients with early symptomatic Alzheimer’s disease (AD) over 3 years, according to Professor Chaur-Jong Hu of the Department of Neurology, Taipei Medical University, who spoke at Advances in Medicine (AIM) 2026. 

Treatment with tirzepatide, compared with lifestyle intervention alone, helps prevent the incidence of new or progressive diabetic retinopathy (DR) and its complications among patients with diabetes and overweight or obesity, suggests a study.

Older adults are no strangers to malnutrition, which has been shown to be associated with chronic diseases and geriatric syndromes such as depression, frailty, sarcopenia, polypharmacy, cognitive impairment, and functional dependence, according to a study.